Serum Institute CEO Adar Poonawalla sells his entire stake in Panacea Biotec
He offloaded his entire stake amounting to Rs 118 crore
The shares were sold through an open market transaction
They were picked by the Serum Institute of India (SII) at the same price
As of March 31 shareholding data, both Poonawalla and SII were public shareholders in the firm
Shares of Panacea Biotec on Monday ended at 1.16% higher than the previous close
